Steven Cohen’s NovoCure NVCR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$9.7M Sell
607,780
-195,340
-24% -$3.26M 0.01% 1373
2026
Q2
$12.2M Sell
803,120
-558,271
-41% -$8.45M 0.01% 1172
2026
Q1
$14.8M Buy
1,361,391
+460,895
+51% +$5.76M 0.02% 987
2025
Q4
$11.6M Buy
900,496
+783,896
+672% +$10.1M 0.01% 1261
2025
Q3
$1.51M Sell
116,600
-353,400
-75% -$4.72M ﹤0.01% 1559
2025
Q2
$8.37M Buy
+470,000
New +$8.19M 0.02% 802
2024
Q2
– Sell
-32,600
Closed -$510K – 2282
2024
Q1
$510K Sell
32,600
-335,800
-91% -$4.94M ﹤0.01% 1645
2023
Q4
$5.5M Buy
368,400
+356,856
+3,091% +$4.78M 0.01% 880
2023
Q3
$186K Sell
11,544
-13,289
-54% -$383K ﹤0.01% 1784
2023
Q2
$1.03M Buy
+24,833
New +$1.54M ﹤0.01% 1137
2019
Q3
– Sell
-8,126
Closed -$514K – 1366
2019
Q2
$514K Sell
8,126
-437
-5% -$22.1K ﹤0.01% 833
2019
Q1
$412K Buy
+8,563
New +$412K ﹤0.01% 886

Other funds holding NVCR

Steven Cohen's NVCR Position: Q3 2026 in Review

Steven Cohen reduced its NovoCure (NVCR) stake by 24% in Q3 2026, selling an estimated $3.26M and leaving 607,780 shares worth $9.7M. The position accounts for 0.01% of the portfolio, ranked #1373.

Steven Cohen first reported a position in NVCR in Q1 2019 and has held it in 12 quarters since. The position peaked at $14.8M in Q1 2026. 242 funds tracked by Wall St. Rank hold NVCR as of Q3 2026.

  • Steven Cohen held 607,780 shares of NovoCure worth $9.7M as of Q3 2026.
  • Steven Cohen sold 195,340 NovoCure shares in Q3 2026, an estimated $3.26M.
  • NovoCure made up 0.01% of Steven Cohen's portfolio in Q3 2026, its #1373 holding.
  • Steven Cohen first reported a position in NovoCure in Q1 2019 and has held it in 12 quarters since.
  • Steven Cohen's NovoCure position peaked at $14.8M in Q1 2026.
  • 242 funds tracked by Wall St. Rank held NovoCure as of Q3 2026.

Based on Point72 Asset Management's 13F filing for Q3 2026, filed 16 Nov 2026.